發(fā)布時(shí)間：2018-05-21 07:01

  本文選題：苯并芘 + 骨髓間充質(zhì)干細(xì)胞��； 參考：《重慶醫(yī)科大學(xué)》2017年博士論文

【摘要】：背景在骨折的愈合過(guò)程中骨髓間充質(zhì)干細(xì)胞(Mesenchymal stem cells,MSCs)對(duì)骨的再生起了重要作用。香煙中的主要成份苯并芘(Benzo[a]pyrene,BaP)是芳香烴受體(arylhydrocarbonreceptor,Ahr)的激動(dòng)劑,可以負(fù)性調(diào)控骨量和成骨分化。目的通過(guò)臨床標(biāo)本、動(dòng)物模型、體外實(shí)驗(yàn)的研究,分析BaP對(duì)MSCs分化能力的影響及作用機(jī)制,探討B(tài)aP是否會(huì)抑制大鼠骨折愈合的進(jìn)程。方法本實(shí)驗(yàn)總共分為三個(gè)部分1.收集來(lái)自吸煙人群的人骨髓間充質(zhì)干細(xì)胞(human bone marrow mesenchymal stem,hBMSCs)檢測(cè)早期成骨標(biāo)志物堿性磷酸酶(alkaline phosphatase,ALP)染色和活性,茜素紅S染色檢測(cè)晚期的鈣鹽沉積。檢測(cè)芳香烴受體和其靶基因細(xì)胞色素P4501B1(cytochrome p4501B1,CYP1B1)的表達(dá)情況,驗(yàn)證長(zhǎng)期吸煙人群的hBMSCs的Ahr信號(hào)通路是否被激活。用BaP處理C3H10T1/2和原代大鼠骨髓間充質(zhì)干細(xì)胞(Bone marrow derived mesenchymal stem cells,BM-MSCs),利用MTT和克隆形成實(shí)驗(yàn)檢測(cè)MSCs的增殖及自我更新能力,利用油紅O染色,檢測(cè)MSCs成脂分化能力,化學(xué)發(fā)光和細(xì)胞化學(xué)染色檢測(cè)ALP變化,茜素紅S染色檢測(cè)鈣鹽沉積,觀察MSCs的成骨分化能力。Western Blot檢測(cè)Ahr信號(hào)相關(guān)分子的表達(dá)情況。為進(jìn)一步明確其具體機(jī)制,采用si Ahr干擾Ahr信號(hào)通路,檢測(cè)si Ahr對(duì)BaP作用下MSCs成骨分化能力:化學(xué)發(fā)光和細(xì)胞化學(xué)染色檢測(cè)ALP變化;茜素紅S染色檢測(cè)鈣鹽沉積;Western Blot檢測(cè)成骨標(biāo)志物成骨特異性轉(zhuǎn)錄因子(Runt-related transcription factor 2,RUNX2),骨橋蛋白(Osteopontin,OPN)以及SMAD依賴信號(hào)通路TGF-β1/SMAD4和非SMAD信號(hào)依賴通路TGF-β1/ERK/AKT的表達(dá)情況。BaP激活A(yù)hr信號(hào)通路的同時(shí)采用TGF-β1抑制劑(LY2157299)驗(yàn)證TGF-β1通路的作用。2.白藜蘆醇作為Ahr的天然抑制劑,與BaP共同作用后分別檢測(cè)成骨分化能力和相關(guān)信號(hào)通路的表達(dá)。體內(nèi)實(shí)驗(yàn),首先構(gòu)建大鼠染毒和骨折模型,Western Blot檢測(cè)BM-MSCs的CYP1B1的表達(dá)情況,確保染毒模型構(gòu)建成功,X線和HE檢測(cè)骨折愈合情況。用白藜蘆醇與BaP共同作用于大鼠,觀察骨折愈合情況。3.骨形態(tài)發(fā)生蛋白(Bone Morphogenetic Proteins,BMPs)作為成骨誘導(dǎo)因子,與BaP共同作用后檢測(cè)成骨分化能力的變化。結(jié)果吸煙人群的hBMSCs自我更新及成骨分化能力減弱,并且激活A(yù)hr信號(hào)通路以及上調(diào)Ahr的靶基因CYP1B1的表達(dá)。體外實(shí)驗(yàn)證實(shí),BaP抑制MSCs的自我更新及多向分化能力,主要是通過(guò)激活A(yù)hr信號(hào)通路抑制SMAD依賴信號(hào)通路TGF-β1/SMAD4和非SMAD信號(hào)依賴通路TGF-β1/ERK/AKT。白藜蘆醇作為Ahr的天然抑制劑,可以抑制BaP對(duì)MSCs的損害。BMP2和BMP9可以抵消BaP抑制成骨分化的作用。體內(nèi)實(shí)驗(yàn)結(jié)果顯示,BaP可以抑制大鼠骨折愈合的進(jìn)程,并且這個(gè)作用會(huì)被白藜蘆醇挽救。結(jié)論1.BaP通過(guò)激活A(yù)hr抑制TGF-β1/SMAD4和TGF-β1/ERK/AKT損傷MSCs的干性。白藜蘆醇可以拮抗Ahr抵消BaP的影響。2.BaP可以抑制骨折的愈合進(jìn)程,并且這個(gè)作用會(huì)被白藜蘆醇挽救。
[Abstract]:Background Mesenchymal stem cells play an important role in bone regeneration during fracture healing. Benzo [a] pyrene-BaPin, the main component of cigarette, is an agonist of aromatic hydrocarbon receptor aryl hydrocarbon receptor Ahr. it can negatively regulate bone mass and osteogenic differentiation. Objective to analyze the effect of BaP on the differentiation ability of MSCs and its mechanism through clinical specimens, animal models and in vitro experiments, and to explore whether BaP can inhibit the process of fracture healing in rats. Methods the experiment was divided into three parts. Human bone marrow mesenchymal stem cells (bone marrow mesenchymal stem cells) from smoking population were collected to detect the early osteogenic marker alkaline phosphatase (ALP) staining and activity. Alizarin red S staining was used to detect the late calcium deposition. The expression of aromatics receptor and its target gene cytochrome P4501B1(cytochrome p4501B1CY CYP1B1) was detected to verify whether the Ahr signaling pathway of hBMSCs was activated in long-term smokers. C3H10T1/2 and primary rat bone marrow mesenchymal stem cells (BM-MSCs) were treated with BaP. The proliferation and self-renewal ability of MSCs were detected by MTT and clone formation assay. The ability of MSCs adipogenic differentiation was detected by oil red O staining. Chemiluminescence and cytochemical staining were used to detect the changes of ALP and alizarin red S staining to detect calcium deposition. The osteogenic differentiation ability of MSCs was observed. Western Blot was used to detect the expression of Ahr signal-related molecules. In order to further clarify its specific mechanism, si Ahr interference Ahr signaling pathway was used to detect the osteogenic differentiation ability of MSCs induced by BaP by si Ahr. The changes of ALP were detected by chemiluminescence and cytochemical staining. Detection of calcium Deposit by alizarin Red S staining Western Blot Detection of Osteopontinopontin Osteopontin Osteopontin Osteopontin (Osteopontin OPN) Osteopontin Osteopontin (Osteopontin OPN) Osteopontin Osteopontin (Osteopontin) and SMAD dependent signaling pathway TGF- 尾 1/ERK/AKT. TGF- 尾 1 inhibitor LY2157299) was used to verify the role of TGF- 尾 1 pathway. Resveratrol, as a natural inhibitor of Ahr, was combined with BaP to detect the osteogenic differentiation ability and the expression of signal pathway. In vivo experiments, the rat model of exposure and fracture was first constructed to detect the expression of BM-MSCs CYP1B1 by Western Blot, and to ensure the successful construction of the model by X-ray and HE detection of fracture healing. Resveratrol combined with BaP was used to observe fracture healing in rats. Bone morphogenetic protein bone Morphogenetic proteins (BMPs) were used as osteogenic inducers, and the changes of osteogenic differentiation ability were detected after combined action of BaP and bone morphogenetic protein (BMP). Results the ability of hBMSCs self-renewal and osteogenic differentiation was weakened in smoking population, and Ahr signaling pathway was activated and CYP1B1 expression of target gene of Ahr was up-regulated. In vitro experiments showed that bap inhibited the self-renewal and multidirectional differentiation of MSCs, mainly by activating the Ahr signaling pathway to inhibit the SMAD dependent signaling pathway TGF- 尾 1/SMAD4 and non-SMAD signaling dependent pathway TGF- 尾 1 / ERK-AKT. Resveratrol as a natural inhibitor of Ahr can inhibit the damage of BaP to MSCs. BMP2 and BMP9 can counteract the inhibitory effect of BaP on osteogenic differentiation. In vivo results showed that Bap inhibited the healing process of fracture in rats, and this effect was resuscitated by resveratrol. Conclusion 1.BaP inhibits the dryness of MSCs induced by TGF- 尾 1/SMAD4 and TGF- 尾 1/ERK/AKT by activating Ahr. Resveratrol antagonized the effect of Ahr on counteracting BaP. 2. Bap inhibited the healing process of fracture, and this effect was saved by resveratrol.
【學(xué)位授予單位】：重慶醫(yī)科大學(xué)
【學(xué)位級(jí)別】：博士
【學(xué)位授予年份】：2017
【分類號(hào)】：R683

【相似文獻(xiàn)】

相關(guān)期刊論文 前10條

1 阿信;;新干細(xì)胞時(shí)代[J];基層醫(yī)學(xué)論壇;2008年03期

2 卓文利;蔡錦全;付云烽;朱榕城;徐廷昭;吳衛(wèi)真;楊順良;譚建明;;超順磁性氧化鐵標(biāo)記對(duì)大鼠骨髓間充質(zhì)干細(xì)胞增殖和分化能力的影響[J];中華細(xì)胞與干細(xì)胞雜志(電子版);2013年01期

3 王之發(fā);翁雁鳴;劉彥普;劉斌;;兔骨髓干細(xì)胞和脂肪干細(xì)胞增殖和分化能力的比較[J];現(xiàn)代生物醫(yī)學(xué)進(jìn)展;2013年11期

4 ;科學(xué)家用磁力駕馭干細(xì)胞[J];生物醫(yī)學(xué)工程與臨床;2013年05期

5 單志新;林秋雄;李曉紅;鄧春玉;周志凌;黃薇;黃曉忠;余細(xì)勇;;腺病毒表達(dá)載體對(duì)骨髓間充質(zhì)干細(xì)胞分化能力的影響[J];南方醫(yī)科大學(xué)學(xué)報(bào);2008年07期

6 杜靜冰;劉宏偉;甄蕾;寧慧影;;單克隆大鼠骨髓基質(zhì)細(xì)胞分化能力異質(zhì)性的實(shí)驗(yàn)研究[J];實(shí)用口腔醫(yī)學(xué)雜志;2011年02期

7 梁華剛;給干細(xì)胞兩個(gè)生命[J];中國(guó)科技信息;2003年01期

8 靜雨;;生物工程為干細(xì)胞研究帶來(lái)新觀點(diǎn)[J];國(guó)外醫(yī)學(xué)情報(bào);2002年07期

9 費(fèi)瑞高;~(226)Ra和X線照射對(duì)小鼠造血干細(xì)胞增殖和分化能力的影響[J];國(guó)外醫(yī)學(xué)(放射醫(yī)學(xué)分冊(cè));1980年03期

10 諸葛棟;梁戰(zhàn)華;宋琳;劉晶;;不同來(lái)源干細(xì)胞神經(jīng)向分化能力的研究現(xiàn)狀[J];中國(guó)組織工程研究與臨床康復(fù);2010年32期

相關(guān)會(huì)議論文 前1條

1 卓文利;蔡錦全;付云烽;朱容城;徐廷昭;吳衛(wèi)真;楊順良;譚建明;;超順磁性氧化鐵標(biāo)記對(duì)大鼠骨髓間充質(zhì)干細(xì)胞增殖和分化能力影響的實(shí)驗(yàn)研究[A];2012中國(guó)器官移植大會(huì)論文匯編[C];2012年

相關(guān)重要報(bào)紙文章 前1條

1 ;干細(xì)胞變化出人體零件[N];中國(guó)醫(yī)藥報(bào);2001年

相關(guān)博士學(xué)位論文 前2條

1 周一青;苯并芘通過(guò)抑制骨髓間充質(zhì)干細(xì)胞自我更新和分化能力影響骨折愈合的研究[D];重慶醫(yī)科大學(xué);2017年

2 楊志崗;CD49f在骨髓間充質(zhì)干細(xì)胞中的作用及調(diào)控機(jī)制研究[D];北京協(xié)和醫(yī)學(xué)院;2015年

相關(guān)碩士學(xué)位論文 前3條

1 王春雷;糖尿病小鼠骨髓間充質(zhì)干細(xì)胞脂向分化能力及EGb761干預(yù)效應(yīng)[D];東南大學(xué);2015年

2 趙喜聰;吸煙者人頜骨骨髓間充質(zhì)干細(xì)胞增殖和骨向分化能力的對(duì)比研究[D];第四軍醫(yī)大學(xué);2012年

3 諸葛棟;骨髓與脂肪間質(zhì)干細(xì)胞神經(jīng)向分化能力比較研究[D];大連醫(yī)科大學(xué);2010年

，

本文編號(hào)：1918216